In Brief This Week: Beckman Coulter; Agilent; Avantra Biosciences, TGen; Eagle Genomics; Exiqon; and More | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Two private equity groups consisting of four firms have made second-round takeover offers for Beckman Coulter, The New York Times and Reuters reported Thursday. Blackstone Group and TPG Capital comprise one bidding group, and Appollo Global Management and the Carlyle Group form the other bidder. Reports have suggested Danaher is interested in Beckman Coulter as well, but neither news organization could confirm if it had also made a bid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.